Better Coronavirus Stock: Moderna vs. Pfizer
Only two coronavirus vaccines have a realistic possibility of becoming available by the end of 2020. Moderna (NASDAQ: MRNA) makes one of the vaccine candidates in the running. Pfizer (NYSE: PFE), along with its partner BioNTech (NASDAQ: BNTX), lays claim to the other contender.
While Moderna and Pfizer share this one important thing in common, the two drugmakers are quite different in many respects. Which of these coronavirus-focused stocks is the better pick for investors over the long term? Here's how Moderna and Pfizer compare.
Image source: Getty Images.
Source Fool.com
